Mark For: TAILOR™ trademark registration is intended to cover the categories of
Research | OneLook Acronym Finder |
Serial Number | 97572946 |
Mark Literal Elements | TAILOR |
Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
Mark Type | Service Mark |
Current Location | NEW APPLICATION PROCESSING 2022-09-03 |
Basis | 1(a) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | Yes |
Current Use | Yes |
Intent To Use | No |
Filed ITU | No |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Alicia Morris Groos |
Attorney Docket Number | BCOM060US |
2020-00-00 | Date of First Use |
2022-08-31 | Application Filed |
2022-09-03 | Date of First Use |
2022-09-03 | Date of Use In Commerce |
2022-09-03 | Location: NEW APPLICATION PROCESSING |
2022-09-03 | Status: Live/Pending |
2022-09-03 | Status: New application will be assigned to an examining attorney approximately 6 months after filing date. |
2022-09-03 | Transaction Date |
Party: | Baylor College of Medicine |
Address | Mail Slot BCM 105, One Baylor Plaza Houston, TEXAS UNITED STATES 77030 |
Legal Entity Type | Non-profit Corporation |
Legal Entity State | TEXAS |
Application | 2022-08-31 | |
Drawing | 2022-08-31 | |
Specimen | 2022-08-31 |
International Codes: | 42 |
U.S. Codes: | 100,101 |
Type Code | Type |
---|---|
GS0421 | Development of therapeutic bacteriophage cocktail compositions and related bacteriophage research and development services; pharmaceutical research and development for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders using bacteriophages; pharmaceutical research in the field of engineered bacteriophage; scientific research, namely, research relating to bacteriophage platforms and bacteriophages for use in connection with a wide variety of therapeutic agents; scientific and technical consulting services relating to producing, assaying, and purifying bacteriophages found in humans and animals |
GS0421 | Development of therapeutic bacteriophage cocktail compositions and related bacteriophage research and development services; pharmaceutical research and development for the purpose of targeting and destroying bacteria; medical research for use in treating antibiotic-resistant bacterial infections and microbiome-related disorders using bacteriophages; pharmaceutical research in the field of engineered bacteriophage; scientific research, namely, research relating to bacteriophage platforms and bacteriophages for use in connection with a wide variety of therapeutic agents; scientific and technical consulting services relating to producing, assaying, and purifying bacteriophages found in humans and animals |
Description | Date | Proceeding Number |
---|---|---|
NEW APPLICATION ENTERED IN TRAM | 2022-09-03 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.